secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-03-13T23:59:59+00:00
Accession:  0001178913-26-000875
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward shareholders approve Oratech Pharma acquisition and related proposals
------------------------------------------------------------------------------

- Proposal 1 passed: issuance of ordinary shares to Oramed for Oratech acquisition (1,854,591 for, 470,084 against).
- Proposal 2 passed: election of two external directors contingent on closing of Oratech acquisition.
- Proposal 5 passed: equity grant to CEO Mark Grant (1,656,670 for, 674,846 against).
- Proposal 6 passed: reappointment of Ernst & Young as auditor for FY 2026 (6,175,644 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326000875/0001178913-26-000875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326000875/zk2634572.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-000875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer